Navita L Mallalieu

4PUBLICATIONS
6CO-AUTHORS
NanomedicinePharmacogenomicsWomen's studies (incl. girls' studies)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 30, 2026
Evidence of intrapulmonary penetration of nacubactam, a novel β-lactamase inhibitor, following coadministration of nacubactam with meropenem in healthy adults.

|Apr 30, 2026
A multi-center, open-label, two-part study to investigate the effect of renal function and hemodialysis on the pharmacokinetics of the novel β-lactamase inhibitor nacubactam.

|Nov 13, 2025
Representation of Older Adult Patients in Clinical Trials.

Sebastian Haertter, Navita L Mallalieu, Soundos Saleh

|Aug 24, 2019
Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial.

Navita L Mallalieu, Sunethra Wimalasundera, Joy C Hsu

Pageof 1

Frequent Collaborators

2 joint publications

Jun Morita

1 joint publications

Sebastian Haertter

1 joint publications

Soundos Saleh

1 joint publications

Paul Goldsmith